Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7342 p360-361
26 March 2005

This article
Reprint   Photocopy

PDF 80K, Acrobat Reader

Letters

· Council election
· The profession (5)
· Community pharmacy (3)
· Revalidation
· The Society
· Prescription charges


Letters to the Editor

Community pharmacy

Concerns about loss of personal control (Mrs V. Taylor)

Let us not underprice our services (Mr P. J. Reeder)

Society should address flaws in pharmacists’ business skills (Mr J. S. Khela)

Concerns about loss of personal control

From Mrs V. Taylor, MRPharmS

On 11 December 2004 the Department of Health published the document “Making the best use of the pharmacy workforce” and released it for consultation (PJ, 18/25 December 2004, p873). The document, which proposed radical changes to personal control in a community pharmacy, seems to have prompted little response from the membership. The closing date for comments is now past. I would like to set out some of my personal concerns.

I believe that careful consideration needs to be taken before changing regulations which have served the public well for many years.

Community pharmacists, at present, are available throughout their working day, without appointment, to give advice to members of the public. This is an important part of their role and enables patients to have unprecedented access to a health care professional. This role fits well with the strong desire of the Government to promote self care. Indeed the role as custodian of medicines has been performed so excellently that there is now a lack of recognition of this vital function of community pharmacists.

Pharmacists also provide a safe supply service of dispensed medicines that enables the patient to receive the correct medicines, labeled correctly in a timely manner following the directions of an accredited prescriber. The final accountability for supply of the appropriate medicines lies with the pharmacist, and as the expert in medicines the advice provided to patients is invaluable.

The consultation document recommends that the pharmacy workforce needs to operate more flexibly. Although changes are taking place within community pharmacy, a needs assessment should be undertaken to ascertain the degree of flexibility required in order to meet these changes and only then should regulatory changes be considered. This assessment needs to be made in the light of the expected availability of funding to pay for delivery of these new roles.

When this work is completed the need for radical change, which is likely to compromise both patient safety and patient access to a community pharmacist on the high street, may not be found to be so imperative.

Vanessa Taylor
Council Election Candidate
Eastbourne, East Sussex


Let us not underprice our services

From Mr P. J. Reeder, MRPharmS

The Royal Pharmaceutical Society’s Code of Ethics requires that “at all times pharmacists must act in the interest of patients and other members of the public and seek to provide the best possible health care for the community in partnership with other professions”. Few could argue with that aim.

If it is to be made acceptable for pharmacists to be away from their premises there is a dilemma.

One of the important features of the service we provide is the ease of access to our skills. Patients can just walk in and ask to speak to us and, if they wish, they can do so anonymously. My patients and customers tell me that they value that facility highly.

If the pharmacist is absent from the pharmacy for long periods then the uniqueness of our service is compromised and I am certain that the health care we provide will deteriorate. Will the activities undertaken by the pharmacist during absence from the premises be of sufficient health care benefit to compensate for this reduced access. I am not convinced that it will.

A less rigid regime permitting some absence may well have some merit. This must be thought through carefully to ensure that we continue to provide prompt and easy access by patients to our skills. We must take care not to get drawn into providing other services which would be more appropriately delivered by doctors or nurses.

The cynical view might be that the Government does not really mind who delivers services as long as the cost is reduced. The cost of medicines use reviews will be about £60 per hour. Doctors’ consulting times will commonly be charged at twice that rate.

Let us ensure that, as a profession, we continue to put patients first, maintaining easy access, and that we do not underprice our services.

Phil Reeder
Lincoln


Society should address flaws in pharmacists’ business skills

From Mr J. S. Khela, MRPharmS

Pharmacists are classically considered as inimitable professionals who amalgamate practice with business skills. Business leadership is ever more important today, especially for the independent contractor. But how does leadership in pharmacies compare with other businesses? How many independents have key visions for their businesses, and if they do, how many employees are aware of them? How many employees are still awaiting appraisals and reviews? Indeed the issues underlying relate to time and cost. As a number of pharmacies fail to recognise this concept so their profits suffer.

Skill mix is an issue in light of the new contract. But such delegation of skills cannot increase our business acumen as we take on more clinical roles. One opening for pharmacy is the Royal Pharmaceutical Society’s proposals to reassess the definition of supervision and personal control (PJ, March 19, p341). However, studies have shown that people feel better and suffer less stress when they are in personal control.1 Does this mean that business leadership needs to be outsourced?

The bottom line is that we cannot be both respectable health professionals and outstanding business leaders under the same hat. As more clinical specialties are introduced we should lever our management abilities. Bona fide success of pharmacy will only be achieved if we have a balance of individuals prepared to work on the job (as leaders) and in the job (as professionals). Workforce may be available as more schools of pharmacies start to open.

There is a need to execute the introduction of business study modules (even as an option) in the undergraduate degree. Such resources to support a multidisciplinary approach, which will create the bigger picture to build awareness and confidence to network beyond a pharmacy scope, are needed. We also need unidisciplinary courses where we have real-life examples of pharmacy and where participants are introduced to skills required for networking with colleagues who can be helpful in their careers and who can act as mentors. Perhaps a cost-effective way of introducing business leadership may be by assigning these tasks to preregistration trainees. Could this be an incentive to counteract the deficient number of preregistration placements currently available?

The Society had little or no input in the negotiation of practice guidance for the new contract. The past does not equal the future; it needs to act now and demonstrate its worth by paying attention to the flaws of our business skills.

Jaggy Khela
Council Election Candidate
Eastleigh, Hampshire

Reference

1. Harrison A. How can pharmacists become effective managers? Hospital Pharmacist 2005;11:325–6

Send your letter to The Editor

Previous Topic (The profession)
Next Topic (Revalidation)

Back to Top


©The Pharmaceutical Journal